Harrow, Inc. (NASDAQ: HROW)
$33.3600
-0.1400 ( +0.79% ) 100.7K
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
Market Data
Open
$33.3600
Previous close
$33.5000
Volume
100.7K
Market cap
$1.16B
Day range
$32.4660 - $35.0050
52 week range
$9.1300 - $59.2300
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
8-k | 8K-related | 18 | May 13, 2024 |
def | Proxies and info statements | 6 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
4 | Insider transactions | 1 | Apr 19, 2024 |